ANIXA BIOSCIENCES, INC. Proceeds from Issuance of Redeemable Preferred Stock
ANIXA BIOSCIENCES, INC. (ANIX) reported Proceeds from Issuance of Redeemable Preferred Stock of $500.00 thousand for the 9-month period ending 2018-07-31, per its 10-Q filed 2018-09-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfRedeemablePreferredStock · last filed 2018-09-07
- 2018-07-31: Proceeds from Issuance of Redeemable Preferred Stock 9 month $500.00K.
| Period end | Proceeds from Issuance of Redeemable Preferred Stock 9 month |
|---|---|
| 2018-07-31 | $500.00K 10-Q · filed 2018-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |